126 related articles for article (PubMed ID: 9307288)
1. Antitumor and radiosensitizing effects of (E)-2'-deoxy-2'-(fluoromethylene) cytidine, a novel inhibitor of ribonucleoside diphosphate reductase, on human colon carcinoma xenografts in nude mice.
Sun LQ; Li YX; Guillou L; Mirimanoff RO; Coucke PA
Cancer Res; 1997 Sep; 57(18):4023-8. PubMed ID: 9307288
[TBL] [Abstract][Full Text] [Related]
2. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Sun LQ; Li YX; Guillou L; Coucke PA
Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
[TBL] [Abstract][Full Text] [Related]
3. Response of human colon and prostate tumor xenografts to (E)-2'-deoxy-2'-(fluoromethylene) cytidine, an inhibitor of ribonucleotide reductase.
Bitonti AJ; Bush TL; Lewis MT; Sunkara PS
Anticancer Res; 1995; 15(4):1179-82. PubMed ID: 7653997
[TBL] [Abstract][Full Text] [Related]
4. Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine.
Coucke PA; Cottin E; Azria D; Martineau P; Adamer F; Decosterd LA; Buchegger F; Do HP
Eur J Cancer; 2004 Jul; 40(10):1572-80. PubMed ID: 15196542
[TBL] [Abstract][Full Text] [Related]
5. The ribonucleoside diphosphate reductase inhibitor (E)-2'-deoxy-(fluoromethylene)cytidine as a cytotoxic radiosensitizer in vitro.
Coucke PA; Decosterd LA; Li YX; Cottin E; Chen X; Sun LQ; Stern S; Paschoud N; Denekamp J
Cancer Res; 1999 Oct; 59(20):5219-26. PubMed ID: 10537300
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
[TBL] [Abstract][Full Text] [Related]
7. Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase.
Bitonti AJ; Dumont JA; Bush TL; Cashman EA; Cross-Doersen DE; Wright PS; Matthews DP; McCarthy JR; Kaplan DA
Cancer Res; 1994 Mar; 54(6):1485-90. PubMed ID: 8137252
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2'-deoxy-2'-(fluoromethylene) cytidine on the ultraviolet and X-ray sensitivity of HeLa cells.
Snyder RD
Oncol Res; 1994; 6(4-5):177-82. PubMed ID: 7841540
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of cytotoxicity and radiosensitization of (E)-2-deoxy-2'-(fluoromethylene) cytidine by pentoxifylline in vitro.
Li YX; Sun LQ; Weber-Johnson K; Paschoud N; Coucke PA
Int J Cancer; 1999 Jan; 80(1):155-60. PubMed ID: 9935246
[TBL] [Abstract][Full Text] [Related]
12. Cytostatic and cytotoxic effects of (E)-2'-deoxy-2'-(fluoromethylene)-cytidine on a solid tumor and a leukemia cell line.
Grie P; Koronkiewicz M; Skierski JS
Acta Biochim Pol; 2000; 47(1):165-71. PubMed ID: 10961690
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
14. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous alteration of de novo and salvage pathway to the deoxynucleoside triphosphate pool by (E)-2'-deoxy-(fluoromethylene)cytidine (FMdC) and zidovudine (AZT) results in increased radiosensitivity in vitro.
Coucke PA; Cottin E; Decosterd LA
Acta Oncol; 2007; 46(5):612-20. PubMed ID: 17562437
[TBL] [Abstract][Full Text] [Related]
16. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL101731, a novel ribonucleoside diphosphate reductase inhibitor.
Piepmeier JM; Rabidou N; Schold SC; Bitonti AJ; Prakash NJ; Bush TL
Cancer Res; 1996 Jan; 56(2):359-61. PubMed ID: 8542592
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors.
Rodriguez GI; Jones RE; Orenberg EK; Stoltz ML; Brooks DJ
Clin Cancer Res; 2002 Sep; 8(9):2828-34. PubMed ID: 12231523
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of 7-N-(2-((2-(gamma-L-glutamylamino) ethyl) dithio) ethyl) mitomycin C (KW2149) against human tumor xenografts serially transplanted into nude mice.
Kubota T; Inada T; Inoue S; Kuzuoka M; Arisawa Y; Suto A; Kodaira S; Ishibiki K; Abe O
Jpn J Clin Oncol; 1989 Sep; 19(3):216-21. PubMed ID: 2554025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
